| Cas No.: | 360-70-3 |
| Chemical Name: | Nandrolone decanoate |
| Synonyms: | 19-nortestosterone 17-decanoate;Nandrolone Decanoate;19-Nortestosterone decanoate;19-Nortestoterone decanoate;4-Isothiocyanatophenyl Hexopyranoside;NANDROLONE DECANOATE, USP;NitroMethane-d3;Deca-Durabolin;Retabolil;Nortestosterone decanoate;Retabolyl;Norandrostenolone decanoate;Deca-Hybolin;Hybolin decanoate;naboline;Salistoperm;Ziremilon;Palactin;Axedanin;Superbolan;Rougerol;Adenocorin;Dimapolan;Anaboline Depot;Anabolin Depot;ndrolone-D;Deca-Durabol;19-Norandrostenolone decanoate;DRG 0264;17beta-Hydroxyestr-4-en-3-one decanoate;17-beta-Hydroxyestr-4-en-3-one decanoate;Nandrolone Decanoate（DECA）;Nandrolone decanoate;H45187T098;UNII-H45187T098;CHEBI:7467;(17-beta)-17-((1-Oxodecyl)oxy)estr-4-en-3-one;Nandrolone decanoate for peak identification, European Pharmacopoeia (EP) Reference Standard;Estr-4-en-3-one, 17-beta-hydroxy-, decanoate;CHEMBL1200946;NANDROLONE DECANOATE [WHO-DD];AKOS025311438;NANDROLONE DECANOATE (EP MONOGRAPH);AC-1484;Estr-4-en-3-one, 17-((1-oxodecyl)oxy)-, (17beta)-;17 beta-hydroxyestr-4-en-3-one 17-decanoate;EINECS 206-639-3;Tox21_111638_1;Nandrolone decanoate for system suitability, European Pharmacopoeia (EP) Reference Standard;HY-13698;Nandrolone decanoate, European Pharmacopoeia (EP) Reference Standard;Nandrobolic L.A.;(17beta)-3-oxoestr-4-en-17-yl decanoate;17beta-Hydroxyestr-4-en-3-one 17-decanoate;Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17.beta.)-;NANDROLONE DECANOATE [EP MONOGRAPH];NANDROLONE DECANOATE [JAN];19-NORTESTOSTERONE 17-DECANOATE;Nandrolone decanoate ciii;Nandrolone 17beta-decanoate;NANDROLONE DECANOATE [MART.];MFCD00135100;NANDROLONE DECANOATE [USAN];NANDROLONE DECANOATE (USP MONOGRAPH);CAS-360-70-3;NANDROLONE DECANOATE [EP IMPURITY];Nandrolone decanoate (JAN/USP);Nandrolone decanoate (USAN:USP:JAN);NANDROLONE DECANOATE [VANDF];Nandrolone decanoate, United States Pharmacopeia (USP) Reference Standard;17B-HYDROXYESTR-4-EN-3-ONE DECANOATE.;NANDROLONE DECANOATE [ORANGE BOOK];NANDROLONEDECANOATE;17 beta Hydroxyestr 4 en 3 one 17 decanoate;NANDROLONE DECANOATE CIII [USP-RS];DTXCID203352;C08154;Deca-Durabolin (TN);NANDROLONE DECANOATE [USP MONOGRAPH];ESTR-4-EN-3-ONE, 17-((1-OXODECYL)OXY)-, (17.BETA.)-;CS-4613;360-70-3;NCGC00159403-04;(1S,2R,10R,11S,14S,15S)-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl decanoate;Q16634231;SCHEMBL27975;Nandrolone Decanoate (~70%);Deca-Durobolin;17.BETA.-HYDROXYESTR-4-EN-3-ONE 17-DECANOATE;Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17b)-;NANDROLONE DECANOATE CIII (USP-RS);Nandrolone decanoate [USAN:USP:JAN];NS00009587;Tox21_111638;NCGC00263561-01;(8R,9S,10R,13S,14S,17S)-13-Methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl decanoate;NANDROLONE DECANOATE;NANDROLONE DECANOATE (MART.);NANDROLONE DECANOATE [MI];BRN 2228051;DB08804;NANDROLONE DECANOATE (EP IMPURITY);19-Nortestosterone-17.beta.-decanoate... |
| SMILES: | O(C(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])=O)[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(C([H])([H])C([H])([H])[C@]4([H])[C@@]3([H])C([H])([H])C([H])([H])[C@@]21C([H])([H])[H])=O |
| Formula: | C28H44O3 |
| M.Wt: | 428.6472 |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|